Metastatic cluster 2-related pheochromocytoma/paraganglioma: a single-center experience and systematic review
Risk of metastatic disease in the cluster 2-related pheochromocytoma/paraganglioma (PPGL) is low. In MEN2 patients, identification of origin of met astases from pheochromocytoma (PCC) or medullary thyroid carcinoma (MTC) is challenging as both are of neuroendocrine origin. We aim to describe our exp...
Guardado en:
Autores principales: | Sandeep Kumar, Anurag Ranjan Lila, Saba Samad Memon, Vijaya Sarathi, Virendra A Patil, Santosh Menon, Neha Mittal, Gagan Prakash, Gaurav Malhotra, Nalini S Shah, Tushar R BandgarDepartment of Endocrinology, Seth G S Medical College & KEM Hospital, Mumbai, India |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Bioscientifica
2021
|
Materias: | |
Acceso en línea: | https://doi.org/10.1530/EC-21-0455 https://doaj.org/article/cefb88e263574b63888ce8b715db67ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas
por: Anastasiya Snezhkina, et al.
Publicado: (2021) -
Case Report: A Case of Moyamoya Syndrome Associated With Multiple Endocrine Neoplasia Type 2A
por: Fumihiro Matano, et al.
Publicado: (2021) -
Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs)
por: Khatami Fatemeh, et al.
Publicado: (2018) -
Local-Regional Recurrence of Pheochromocytoma/Paraganglioma: Characteristics, Risk Factors and Outcomes
por: Yunying Cui, et al.
Publicado: (2021) -
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy
por: Letizia Canu, et al.
Publicado: (2021)